Aktie 936191 BLONDER TONGUE LABORATORIES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Blonder Tongue Laboratories, Inc.

Aktien

936191

US0936981085

BDRL

Markt geschlossen - OTC Markets
Andere Börsenplätze
 16:58:06 13.05.2024 		% 5 Tage % 1. Jan.
0,1141 USD -12,24 % Intraday Chart für Blonder Tongue Laboratories, Inc. -12,23 % +40,00 %
2023 Blonder Tongue kündigt IP-Failover-Funktion für das NXG Video Delivery System an CI
2023 Blonder Tongue Laboratories, Inc. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System
BLONDER TONGUE LABORATORIES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002.
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Blonder Tongue Laboratories, Inc. Auditor Raises 'Going Concern' Doubt
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Blonder Tongue Announces Demise of Eric Skolnik, Senior Vice President
Blonder Tongue Announces Demise of Eric Skolnik, Chief Financial Officer; Appoints Michael Censoplano as Interim CFO
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Blonder Tongue Laboratories, Inc. Announces President Changes
Blonder Tongue Laboratories, Inc. Announces Chief Executive Officer Changes
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
BLONDER TONGUE LABORATORIES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002.
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Earnings Flash (BDRL) BLONDER TONGUE LABORATORIES Posts Q3 Revenue $5.3M
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 936191 Aktie
  4. Nachrichten Blonder Tongue Laboratories, Inc.
  5. Andere Sprachen